The primary objective is to investigate whether the rebreathing apparatus or the steady-state apparatus should be used as a diagnostic tool in the MST. The primary objective is answer by means of sub questions, which involve; the repeatability of…
ID
Bron
Verkorte titel
Aandoening
healthy subjects
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The main study endpoint is the reproducibility of the measurements. Sensitivity slope (L/min per kPa) of the curve is calculated by means of linear regression. To assess the repeatability of both methods, the ICC is calculated between the paired CO2 sensitivity slopes of the first and second rebreathing measurement and between the first and second steady-state measurement
Achtergrond van het onderzoek
Effects of increasing/decreasing levels of CO2 on ventilation can be studied using the hypercapnic ventilatory response (HCVR). In various patient groups the HCVR is disturbed. Two methods are known to measure the HCVR, the rebreathing and steady-state method. Both methods can measure the ventilation response to CO2, therefore in this study the two methods will be compared. Computer controlled systems are not available for use, due to high costs to persuade or built them. In this study two self-made apparatuses are built, based on literature. The aim of the study is to find out which method is to be implemented in the clinic, as a diagnostic tool, on basis of the repeatability of both tests.
Doel van het onderzoek
The primary objective is to investigate whether the rebreathing apparatus or the steady-state apparatus should be used as a diagnostic tool in the MST. The primary objective is answer by means of sub questions, which involve; the repeatability of both methods, experiences of the subjects, costs and time duration of both methods.
Onderzoeksopzet
Measurements are performed with 20 subjects. Two appointments per subject are made, the second measurement is within 5-9 days after the first. At both appointments HCVR is measured with both methods. At the first appointment the order is determined with a randomisation list (rebreathing steady-state or steady-state rebreathing).
Onderzoeksproduct en/of interventie
not applicable
Algemeen / deelnemers
D.C. Mannée
Groesbeek 6561 KE
The Netherlands
+31 (0) 6 15 43 33 75
denise.mannee@radboudumc.nl
Wetenschappers
D.C. Mannée
Groesbeek 6561 KE
The Netherlands
+31 (0) 6 15 43 33 75
denise.mannee@radboudumc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
healthy, adult aged between 18 and 65
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
history of cardio-pulmonary disease, neuro(muscular) disease, and/or kyphoscoliosis; unable to understand and read the English or Dutch language; drug abuse; use of respiratory stimulants or depressant; and pregnant women
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL6115 |
NTR-old | NTR6254 |
CCMO | NL60541.044.17 |
OMON | NL-OMON45318 |